Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2014 Filed Feb 11, 2019 23:32 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,763 | $3.89 Strike: $3.89 | $49,648.07 |
DisclosureSEC source: 0001096906-19-000059 · primary_doc.xml · derivative · entry 3 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,763 Underlying: Class A Common Stock · 12,763 shares Expires 2024-12-05 F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 11, 2019 23:06 UTC |
Sill Garrett S.CFO; Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,210 | $3.89 Strike: $3.89 | $39,716.90 |
DisclosureSEC source: 0001096906-19-000058 · primary_doc.xml · derivative · entry 4 Sill Garrett S. · CIK 0001568673 · CFO; Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,210 Underlying: Class A Common Stock · 10,210 shares Expires 2024-12-05 F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · balance_after: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 13, 2019 18:26 UTC |
Quist S. AndrewDirector · VP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,527 | $3.89 Strike: $3.89 | $99,300.03 |
DisclosureSEC source: 0001096906-19-000063 · primary_doc.xml · derivative · entry 5 Quist S. Andrew · CIK 0001588309 · Director · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,527 Underlying: Class A Common Stock · 25,527 shares Expires 2024-12-05 F6 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · shares: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · price: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · balance_after: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 20, 2019 20:23 UTC |
Stephens Jeffrey RussellSr. Gen Council; Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000073 · primary_doc.xml · derivative · entry 5 Stephens Jeffrey Russell · CIK 0001488171 · Sr. Gen Council; Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F6 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 21, 2019 21:14 UTC |
Johnson Stephen CharlesVP Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,658 | $3.89 Strike: $3.89 | $29,789.62 |
DisclosureSEC source: 0001096906-19-000074 · primary_doc.xml · derivative · entry 5 Johnson Stephen Charles · CIK 0001661597 · VP Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,658 Underlying: Class A Common Stock · 7,658 shares Expires 2024-12-05 F6 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · shares: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · price: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F6 · balance_after: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 22, 2019 21:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000077 · primary_doc.xml · derivative · entry 12 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F12 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 22, 2019 21:57 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 127,629 | $4.27 Strike: $4.27 | $544,975.83 |
DisclosureSEC source: 0001096906-19-000078 · primary_doc.xml · derivative · entry 3 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,629 Underlying: Class C Common Stock · 127,629 shares Expires 2019-12-05 F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 22, 2019 18:53 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000076 · primary_doc.xml · derivative · entry 12 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F12 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F12 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 22, 2019 17:51 UTC |
Quist Adam GeorgeVP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,553 | $3.89 Strike: $3.89 | $9,931.17 |
DisclosureSEC source: 0001096906-19-000075 · primary_doc.xml · derivative · entry 2 Quist Adam George · CIK 0001740330 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,553 Underlying: Class A Common Stock · 2,553 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1 2019. F3 · shares: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1 2019. F3 · price: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1 2019. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1 2019. F3 · balance_after: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1 2019. Read SEC document |
| December 05, 2014 Filed Feb 25, 2019 16:47 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,527 | $3.89 Strike: $3.89 | $99,300.03 |
DisclosureSEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 4 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,527 Underlying: Class A Common Stock · 25,527 shares Expires 2024-12-05 F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Apr 19, 2019 23:02 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000148 · primary_doc.xml · derivative · entry 5 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F2 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · shares: This option was granted on December 5, 2014 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · price: This option was granted on December 5, 2014 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · balance_after: This option was granted on December 5, 2014 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed May 22, 2019 19:07 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,763 | $3.89 Strike: $3.89 | $49,648.07 |
DisclosureSEC source: 0001096906-19-000216 · primary_doc.xml · derivative · entry 4 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,763 Underlying: Class A Common Stock · 12,763 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · shares: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · price: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Jul 8, 2019 20:35 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 127,629 | $4.27 Strike: $4.27 | $544,975.83 |
DisclosureSEC source: 0001096906-19-000256 · primary_doc.xml · derivative · entry 3 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,629 Underlying: Class C Common Stock · 127,629 shares Expires 2019-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · balance_after: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Aug 1, 2019 17:36 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 127,629 | $4.27 Strike: $4.27 | $544,975.83 |
DisclosureSEC source: 0001096906-19-000271 · primary_doc.xml · derivative · entry 5 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,629 Underlying: Class C Common Stock · 127,629 shares Expires 2019-12-05 F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · balance_after: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 17, 2019 18:42 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000423 · primary_doc.xml · derivative · entry 11 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F11 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 17, 2019 20:19 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000427 · primary_doc.xml · derivative · entry 13 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F11 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F11 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 17, 2019 21:37 UTC |
Sill Garrett S.CFO; Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,210 | $3.89 Strike: $3.89 | $39,716.90 |
DisclosureSEC source: 0001096906-19-000429 · primary_doc.xml · derivative · entry 3 Sill Garrett S. · CIK 0001568673 · CFO; Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,210 Underlying: Class A Common Stock · 10,210 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · balance_after: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 17, 2019 17:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000420 · primary_doc.xml · derivative · entry 4 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 17, 2019 17:04 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000417 · primary_doc.xml · derivative · entry 3 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 19, 2019 18:40 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,527 | $3.89 Strike: $3.89 | $99,300.03 |
DisclosureSEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 3 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,527 Underlying: Class A Common Stock · 25,527 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 19, 2019 18:01 UTC |
Stephens Jeffrey RussellSr. Gen Council; Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-19-000432 · primary_doc.xml · derivative · entry 4 Stephens Jeffrey Russell · CIK 0001488171 · Sr. Gen Council; Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 20, 2019 18:14 UTC |
Quist S. AndrewDirector · VP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,527 | $3.89 Strike: $3.89 | $99,300.03 |
DisclosureSEC source: 0001096906-19-000436 · primary_doc.xml · derivative · entry 6 Quist S. Andrew · CIK 0001588309 · Director · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,527 Underlying: Class A Common Stock · 25,527 shares Expires 2024-12-05 F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · shares: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · price: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F5 · balance_after: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 20, 2019 17:08 UTC |
Johnson Stephen CharlesVP Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,658 | $3.89 Strike: $3.89 | $29,789.62 |
DisclosureSEC source: 0001096906-19-000435 · primary_doc.xml · derivative · entry 4 Johnson Stephen Charles · CIK 0001661597 · VP Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,658 Underlying: Class A Common Stock · 7,658 shares Expires 2024-12-05 F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Dec 20, 2019 16:35 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,763 | $3.89 Strike: $3.89 | $49,648.07 |
DisclosureSEC source: 0001096906-19-000434 · primary_doc.xml · derivative · entry 3 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 12,763 shares Expires 2024-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · shares: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · price: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F2 · balance_after: This option was granted on December 5, 2014 as an option to purchase 10,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Jan 6, 2020 23:27 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 127,629 | $4.27 Strike: $4.27 | $544,975.83 |
DisclosureSEC source: 0001096906-20-000004 · primary_doc.xml · derivative · entry 4 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Stock · 127,629 shares Expires 2019-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Jan 6, 2020 22:47 UTC |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 127,629 | $4.27 Strike: $4.27 | $544,975.83 |
DisclosureSEC source: 0001096906-20-000003 · primary_doc.xml · derivative · entry 4 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class C Common Stock · 127,629 shares Expires 2019-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · price: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F4 · balance_after: This option was granted on December 5, 2014 as an option for either 100,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 100,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Jan 6, 2020 18:38 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,382 | $3.89 Strike: $3.89 | $24,825.98 |
DisclosureSEC source: 0001096906-20-000002 · primary_doc.xml · derivative · entry 11 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Underlying: Class A Common Stock · 6,382 shares Expires 2024-12-05 F9 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F9 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F9 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F9 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F9 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Jan 15, 2020 20:19 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,527 | $3.89 Strike: $3.89 | $99,300.03 |
DisclosureSEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 8 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,527 Underlying: Class A Common Stock · 25,527 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, and February 1, 2019. Read SEC document |
| December 05, 2014 Filed Feb 12, 2020 16:40 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001096906-20-000067 · primary_doc.xml · derivative · entry 5 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Feb 12, 2020 18:18 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001096906-20-000072 · primary_doc.xml · derivative · entry 3 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Feb 12, 2020 20:23 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001096906-20-000075 · primary_doc.xml · derivative · entry 8 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F8 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F8 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed May 1, 2020 21:41 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000523 · primary_doc.xml · derivative · entry 11 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F7 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed May 7, 2020 22:53 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000573 · form4.xml · derivative · entry 3 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed May 8, 2020 17:03 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000586 · form4.xml · derivative · entry 11 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F7 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed May 8, 2020 15:15 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000584 · form4.xml · derivative · entry 4 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed May 8, 2020 14:15 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.30 Strike: $3.30 | $22,113.30 |
DisclosureSEC source: 0001445866-20-000580 · form4.xml · derivative · entry 9 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F9 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 3, 2020 22:58 UTC Amendment |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000811 · form4.xml · derivative · entry 7 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F7 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 3, 2020 22:22 UTC Amendment |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.30 Strike: $3.30 | $22,113.30 |
DisclosureSEC source: 0001445866-20-000809 · form4.xml · derivative · entry 9 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F9 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F9 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 3, 2020 21:39 UTC Amendment |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000805 · form4.xml · derivative · entry 3 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 3, 2020 22:09 UTC Amendment |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000807 · form4.xml · derivative · entry 4 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F4 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F4 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 9, 2020 21:22 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000833 · primary_doc.xml · derivative · entry 5 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F6 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 9, 2020 19:27 UTC Amendment |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,721 | $3.70 Strike: $3.70 | $39,667.70 |
DisclosureSEC source: 0001445866-20-000830 · primary_doc.xml · derivative · entry 4 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,721 Underlying: Class A Common Stock · 10,721 shares Expires 2024-12-05 F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · balance_after: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 9, 2020 17:57 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,721 | $3.70 Strike: $3.70 | $39,667.70 |
DisclosureSEC source: 0001445866-20-000828 · form4.xml · derivative · entry 4 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,721 Underlying: Class A Common Stock · 10,721 shares Expires 2024-12-05 F5 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · price: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F5 · balance_after: This option was granted on December 5, 2014 as an option for 8,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 10, 2020 16:07 UTC |
Johnson Stephen CharlesVP - Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,041 | $3.70 Strike: $3.70 | $29,751.70 |
DisclosureSEC source: 0001445866-20-000834 · primary_doc.xml · derivative · entry 5 Johnson Stephen Charles · CIK 0001661597 · VP - Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,041 Underlying: Class A Common Stock · 8,041 shares Expires 2024-12-05 F6 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · shares: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · price: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · balance_after: This option was granted on December 5, 2014 as an option for 6,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 11, 2020 19:21 UTC |
Quist S. AndrewDirector · Vice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,803 | $3.70 Strike: $3.70 | $99,171.10 |
DisclosureSEC source: 0001445866-20-000838 · primary_doc.xml · derivative · entry 5 Quist S. Andrew · CIK 0001588309 · Director · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,803 Underlying: Class A Common Stock · 26,803 shares Expires 2024-12-05 F6 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · shares: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · price: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F6 · balance_after: This option was granted on December 5, 2014 as an option for 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 11, 2020 22:31 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,701 | $3.70 Strike: $3.70 | $24,793.70 |
DisclosureSEC source: 0001445866-20-000840 · form4.xml · derivative · entry 9 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 Underlying: Class A Common Stock · 6,701 shares Expires 2024-12-05 F7 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F7 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 12, 2020 20:05 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,803 | $3.70 Strike: $3.70 | $99,171.10 |
DisclosureSEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 2 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,803 Underlying: Class A Common Stock · 26,803 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · price: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. F3 · balance_after: This option was granted on December 5, 2014 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jun 12, 2020 18:55 UTC |
Quist Adam GeorgeVice Pres / General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,681 | $3.70 Strike: $3.70 | $9,919.70 |
DisclosureSEC source: 0001445866-20-000843 · primary_doc.xml · derivative · entry 2 Quist Adam George · CIK 0001740330 · Vice Pres / General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,681 Underlying: Class A Common Stock · 2,681 shares Expires 2024-12-05 F3 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F3 · shares: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F3 · price: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F3 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. F3 · balance_after: This option was granted on December 5, 2014 as an option for 2,000 shares of Class A Common Stock at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the Amended and Restated 2013 Stock Option and Other Equity Incentive Awards Plan (the "2013 Stock Option Plan") to reflect 5% stock dividends paid on February 5, 2016, February 3, 2017, February 2, 2018, February 1 2019, and February 7, 2020. Read SEC document |
| December 05, 2014 Filed Jul 24, 2020 00:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,869 | $3.61 Strike: $3.61 | $24,797.09 |
DisclosureSEC source: 0001445866-20-001040 · primary_doc.xml · derivative · entry 8 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,869 Underlying: Class A Common Stock · 6,869 shares Expires 2024-12-05 F8 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| December 05, 2014 Filed Jul 23, 2020 22:58 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 6,869 | $3.22 Strike: $3.22 | $22,118.18 |
DisclosureSEC source: 0001445866-20-001039 · primary_doc.xml · derivative · entry 10 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,869 Underlying: Class A Common Stock · 6,869 shares Expires 2024-12-05 F10 · derivative.exercise_price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · price: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · derivative.underlying_shares: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F10 · balance_after: This option was granted on December 5, 2014 as an option for 5,000 shares of Class A Common Stock under the Amended and Restated 2014 Director Stock Option Plan (the "2014 Director Stock Option Plan") at an exercise price of $5.02 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 6, 2015, February 5, 2016, February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.